Tanvex BioPharma Inc (泰福生技), which focuses on supplying safe and affordable biosimilars, has obtained marketing approval in Canada for its TX01, a biosimilar of Neupogen (filgrastim), the company said yesterday.
Tanvex has signed contracts with Canada-based Mint Pharmaceuticals Inc authorizing the firm to sell TX01 in Canada, it said in a statement.
It is not known when sales of the drug would begin, as discussions with importers are required first and the COVID-19 pandemic might disrupt distribution, Tanvex said.
The prices for TX01 have yet to be decided, as the company still has to negotiate with private insurers, it said.
The gap between the prices of brand drugs and biosimilars is smaller than between brand drugs and generic drugs, as biosimilars require more research and development, and are more complex than generic drugs, Tanvex said.
Sales in Canada of Neupogen and its biosimilars reached more than C$100 million (US$80.68 million) in the 12 months to June, Tanvex said.
Amgen Inc’s Neupogen is used to treat chemotherapy-induced neutropenia and decreases the incidence of infection caused by febrile neutropenia, the company said.
Amgen filed a patent infringement claim against Tanvex in July 2019, but Tanvex reached an agreement with Amgen in March last year.
The company declined to reveal how much it agreed to pay Amgen.
“The expense was lower than the legal expenses if we had chosen to continue engaging in a lawsuit with Amgen,” a company official said by telephone yesterday.
Tanvex said obtaining approval in Canada has made it more confident of receiving approval from the US Food and Drug Administration (FDA), adding that it applied for a biologics license with the agency in October 2018.
The company expects to gain approval from the US FDA in the third quarter of next year, it said.
Tanvex’s cumulative revenue totaled NT$560,000 (US$19,989) for the first three quarters, up 86 percent from a year earlier.
For the first two quarters, it registered a net loss of NT$793 million, less than its net loss of NT$1.17 billion a year earlier, company data showed.
The Eurovision Song Contest has seen a surge in punter interest at the bookmakers, becoming a major betting event, experts said ahead of last night’s giant glamfest in Basel. “Eurovision has quietly become one of the biggest betting events of the year,” said Tomi Huttunen, senior manager of the Online Computer Finland (OCS) betting and casino platform. Betting sites have long been used to gauge which way voters might be leaning ahead of the world’s biggest televised live music event. However, bookmakers highlight a huge increase in engagement in recent years — and this year in particular. “We’ve already passed 2023’s total activity and
Nvidia Corp CEO Jensen Huang (黃仁勳) today announced that his company has selected "Beitou Shilin" in Taipei for its new Taiwan office, called Nvidia Constellation, putting an end to months of speculation. Industry sources have said that the tech giant has been eyeing the Beitou Shilin Science Park as the site of its new overseas headquarters, and speculated that the new headquarters would be built on two plots of land designated as "T17" and "T18," which span 3.89 hectares in the park. "I think it's time for us to reveal one of the largest products we've ever built," Huang said near the
China yesterday announced anti-dumping duties as high as 74.9 percent on imports of polyoxymethylene (POM) copolymers, a type of engineering plastic, from Taiwan, the US, the EU and Japan. The Chinese Ministry of Commerce’s findings conclude a probe launched in May last year, shortly after the US sharply increased tariffs on Chinese electric vehicles, computer chips and other imports. POM copolymers can partially replace metals such as copper and zinc, and have various applications, including in auto parts, electronics and medical equipment, the Chinese ministry has said. In January, it said initial investigations had determined that dumping was taking place, and implemented preliminary
Intel Corp yesterday reinforced its determination to strengthen its partnerships with Taiwan’s ecosystem partners including original-electronic-manufacturing (OEM) companies such as Hon Hai Precision Industry Co (鴻海精密) and chipmaker United Microelectronics Corp (UMC, 聯電). “Tonight marks a new beginning. We renew our new partnership with Taiwan ecosystem,” Intel new chief executive officer Tan Lip-bu (陳立武) said at a dinner with representatives from the company’s local partners, celebrating the 40th anniversary of the US chip giant’s presence in Taiwan. Tan took the reins at Intel six weeks ago aiming to reform the chipmaker and revive its past glory. This is the first time Tan
RSS